Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 70, 2017
Previous Article Next Article

Folate chitosan conjugated doxorubicin and pyropheophorbide acid nanoparticles (FCDP–NPs) for enhance photodynamic therapy

Author affiliations

Abstract

We prepared new folate chitosan conjugated doxorubicin (DOX) and pyropheophorbide acid (PPa) nanoparticles (FCDP–NPs) using an ionic gelation method with tripolyphosphate (TPP) to enhance photodynamic therapy activity, based on the considerations of the long absorption wavelength (683 nm) of pyropheophorbide acid (PPa) in water and the excellent chemotherapeutic characteristics of doxorubicin (DOX) in cancer therapy. The obtained FCDP–NPs demonstrated a typical spherosome structure, a strong near infrared (NIR) absorption (705 nm) and significantly improved stability and dispersity in PBS (pH = 5, 7, 9); as well as a high singlet oxygen quantum yield (ΦΔ = 64%) compared to free PPa (ΦΔ = 59.1%). In addition, the in vitro cell experiments suggested that FCDP–NPs could be uptaken by HepG2 cells quickly and were mainly located in the cell nucleus. FCDP–NPs showed improved PDT efficiency over pure PPa and DOX at the same concentration after irradiation. Specifically, FCDP–NPs could lead to a 92% inhibition rate on HepG2 cells at 40 μg mL−1 (equal to 6 μg mL−1 DOX). However, the pure DOX showed little cytotoxicity at 6 μg mL−1, which suggests that a small amount of DOX could effectively enhance the PDT activities of PPa and lead to little “dark” cytotoxicity. Moreover, cell morphological changes after PDT treatment further indicated that FCDP–NPs could induce damage and apoptotic cell death efficiently. Finally, the photochemical mechanism of FCDP–NPs during PDT process was investigated by using specific quenching agents sodium azide (SA, a single oxygen quencher) and D-mannitol (DM, a hydroxyl radicals quencher), respectively. The results suggested that Type I and Type II photodynamic reactions can occur simultaneously, yet Type I reaction (the generation of hydroxyl radicals) might play a more important role. All these studies indicated that the FCDP–NPs could be potential nanoparticles in photodynamic cancer treatment.

Graphical abstract: Folate chitosan conjugated doxorubicin and pyropheophorbide acid nanoparticles (FCDP–NPs) for enhance photodynamic therapy

Back to tab navigation

Article information


Submitted
08 Aug 2017
Accepted
07 Sep 2017
First published
15 Sep 2017

This article is Open Access

RSC Adv., 2017,7, 44426-44437
Article type
Paper

Folate chitosan conjugated doxorubicin and pyropheophorbide acid nanoparticles (FCDP–NPs) for enhance photodynamic therapy

W. Li, G. Tan, H. Zhang, Z. Wang and Y. Jin, RSC Adv., 2017, 7, 44426
DOI: 10.1039/C7RA08757H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material.

Reproduced material should be attributed as follows:

  • For reproduction of material from NJC:
    [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
  • For reproduction of material from PCCP:
    [Original citation] - Published by the PCCP Owner Societies.
  • For reproduction of material from PPS:
    [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
  • For reproduction of material from all other RSC journals:
    [Original citation] - Published by The Royal Society of Chemistry.

Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.


Social activity

Search articles by author

Spotlight

Advertisements